Načítá se...
Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy
Dose-limiting peripheral neuropathy (PN) is frequently reported with the use of thalidomide and bortezomib, novel proteasome inhibitors. While these two agents have significant activity in multiple myeloma (MM), the combination and the associated PN have not been fully examined in untreated patients...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3741683/ https://ncbi.nlm.nih.gov/pubmed/19192067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1529-8027.2008.00193.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|